Medico Remedies Limited, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions. Founded in 2004, the company has established itself as a trusted provider of high-quality healthcare solutions, focusing on the development and manufacturing of a diverse range of pharmaceutical products. Specialising in formulations, Medico Remedies offers unique products that cater to both chronic and acute health conditions, ensuring efficacy and safety. The company’s commitment to innovation and quality has earned it a significant market position, with notable achievements in regulatory compliance and product development. Medico Remedies Limited continues to enhance its reputation as a reliable partner in healthcare, dedicated to improving patient outcomes through its comprehensive portfolio of medicines.
How does Medico Remedies Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Medico Remedies Limited's score of 14 is lower than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medico Remedies Limited, headquartered in India, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. In the context of the pharmaceutical industry, where sustainability and climate action are increasingly critical, Medico Remedies Limited may need to consider developing a comprehensive strategy to measure and reduce its carbon footprint. This could involve setting science-based targets and participating in initiatives such as the Science Based Targets initiative (SBTi) to align with global climate goals. As of now, without any emissions data or reduction initiatives, Medico Remedies Limited's climate commitments remain unclear, highlighting an opportunity for the company to enhance its environmental responsibility and transparency in the future.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Medico Remedies Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
